Dr Sybil Tasker | Chief Medical Officer

Dr Sybil Tasker, Chief Medical Officer, Altimmune

Sybil Tasker, MD, MPH, FACP, FIDSA – Senior Vice President of Clinical Research and Development. 
Dr. Tasker joined the Company in April 2016, and is an experienced infectious disease clinician and fellow of the American College of Physicians and the Infectious Diseases Society of America. Prior to joining, she led development of a therapeutic herpes simplex vaccine at Genocea Biosciences and had positions of increasing responsibility in infectious disease product development strategy at two global CROs. A prior career military officer, she was the senior U.S. Navy infectious disease physician and technical advisor to Department of Defense leaders about a wide variety of infectious disease policy issues, including HIV, tropical disease, vaccination, infection control, bioterrorism and pandemic preparedness. She has extensive antimicrobial, vaccine and infectious disease related device and diagnostic development experience across all phases of the clinical development process. She holds a California medical license and is board certified in both internal medicine and infectious diseases. Dr. Tasker earned an A.B. degree in Biochemistry from Princeton University, an Masters in Public Health from Johns Hopkins University and an M.D. degree from Columbia University.


Agenda Day 1 @ 3:00

Nasal vaccination for respiratory infections

  • Introduction to technology platform; mobilizing the immune system in ways conventional vaccines cannot
  • Key advantages of nasal vaccination
  • NasoVAX seasonal influenza clinical program updates

back to speakers